Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,973 | -24,342 | -97,217 | -76,246 | -32,385 |
| Depreciation Amortization | 936 | 1,132 | 1,530 | 1,301 | 534 |
| Accounts payable and accrued liabilities | 33,993 | -2,919 | 6,896 | -3,449 | 6,215 |
| Other Working Capital | 38,203 | -1,827 | 9,076 | -4,635 | -104 |
| Other Operating Activity | -14,411 | -88,973 | -2,310 | 5,515 | -4,456 |
| Operating Cash Flow | $-32,252 | $-116,929 | $-82,025 | $-77,514 | $-30,196 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -581 | -103 | -414 | -2,712 | -22,214 |
| Investing Cash Flow | $-581 | $-103 | $-414 | $-2,712 | $-22,214 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 90 | 124,470 | 2,560 | 47,804 | 192,341 |
| Other Financing Activity | -329 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-239 | $124,470 | $2,560 | $47,804 | $192,341 |
| Beginning Cash Position | 128,574 | 121,136 | 201,015 | 233,437 | 93,506 |
| End Cash Position | 95,502 | 128,574 | 121,136 | 201,015 | 233,437 |
| Net Cash Flow | $-33,072 | $7,438 | $-79,879 | $-32,422 | $139,931 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,252 | -116,929 | -82,025 | -77,514 | -30,196 |
| Capital Expenditure | -581 | -103 | -414 | -2,712 | -22,214 |
| Free Cash Flow | -32,833 | -117,032 | -82,439 | -80,226 | -52,410 |